248 related articles for article (PubMed ID: 20975033)
1. A novel atrial natriuretic peptide based therapeutic in experimental angiotensin II mediated acute hypertension.
McKie PM; Cataliotti A; Boerrigter G; Chen HH; Sangaralingham SJ; Martin FL; Ichiki T; Burnett JC
Hypertension; 2010 Dec; 56(6):1152-9. PubMed ID: 20975033
[TBL] [Abstract][Full Text] [Related]
2. M-atrial natriuretic peptide and nitroglycerin in a canine model of experimental acute hypertensive heart failure: differential actions of 2 cGMP activating therapeutics.
McKie PM; Cataliotti A; Ichiki T; Sangaralingham SJ; Chen HH; Burnett JC
J Am Heart Assoc; 2014 Jan; 3(1):e000206. PubMed ID: 24385449
[TBL] [Abstract][Full Text] [Related]
3. M-atrial natriuretic peptide: a novel antihypertensive protein therapy.
McKie PM; Ichiki T; Burnett JC
Curr Hypertens Rep; 2012 Feb; 14(1):62-9. PubMed ID: 22135207
[TBL] [Abstract][Full Text] [Related]
4. A human atrial natriuretic peptide gene mutation reveals a novel peptide with enhanced blood pressure-lowering, renal-enhancing, and aldosterone-suppressing actions.
McKie PM; Cataliotti A; Huntley BK; Martin FL; Olson TM; Burnett JC
J Am Coll Cardiol; 2009 Sep; 54(11):1024-32. PubMed ID: 19729120
[TBL] [Abstract][Full Text] [Related]
5. Dose-response study of atrial natriuretic peptide bolus injection in healthy man.
Eiskjaer H; Pedersen EB
Eur J Clin Invest; 1993 Jan; 23(1):37-45. PubMed ID: 8383057
[TBL] [Abstract][Full Text] [Related]
6. Pressure-dependent, enhanced natriuretic response to low-dose, atrial natriuretic peptide infusion in essential hypertension.
Eiskjaer H; Nielsen CB; Pedersen EB
J Intern Med; 1994 Dec; 236(6):665-74. PubMed ID: 7989902
[TBL] [Abstract][Full Text] [Related]
7. Cardiovascular, renal, and endocrine response to atrial natriuretic peptide in angiotensin II mediated hypertension.
Edwards BS; Schwab TR; Zimmerman RS; Heublein DM; Jiang NS; Burnett JC
Circ Res; 1986 Dec; 59(6):663-7. PubMed ID: 2949886
[TBL] [Abstract][Full Text] [Related]
8. The effects of atrial natriuretic peptide on renal function and the renin-aldosterone system in anesthetized rabbits.
Nushiro N; Abe K; Seino M; Itoh S; Yoshinaga K
Tohoku J Exp Med; 1987 Jul; 152(3):301-10. PubMed ID: 2958960
[TBL] [Abstract][Full Text] [Related]
9. Differing biological effects of equimolar atrial and brain natriuretic peptide infusions in normal man.
Hunt PJ; Espiner EA; Nicholls MG; Richards AM; Yandle TG
J Clin Endocrinol Metab; 1996 Nov; 81(11):3871-6. PubMed ID: 8923831
[TBL] [Abstract][Full Text] [Related]
10. Modulation of the natriuretic response to atrial natriuretic peptide by alterations in peritubular Starling forces in the rat.
Mendez RE; Dunn BR; Troy JL; Brenner BM
Circ Res; 1986 Dec; 59(6):605-11. PubMed ID: 2949885
[TBL] [Abstract][Full Text] [Related]
11. Activation of myocardial and renal natriuretic peptides during acute intravascular volume overload in dogs: functional cardiorenal responses to receptor antagonism.
Borgeson DD; Stevens TL; Heublein DM; Matsuda Y; Burnett JC
Clin Sci (Lond); 1998 Aug; 95(2):195-202. PubMed ID: 9680502
[TBL] [Abstract][Full Text] [Related]
12. TRV120027, a novel β-arrestin biased ligand at the angiotensin II type I receptor, unloads the heart and maintains renal function when added to furosemide in experimental heart failure.
Boerrigter G; Soergel DG; Violin JD; Lark MW; Burnett JC
Circ Heart Fail; 2012 Sep; 5(5):627-34. PubMed ID: 22891045
[TBL] [Abstract][Full Text] [Related]
13. Atrial natriuretic peptide attenuates pressor but enhances natriuretic responses to angiotensin II in pregnant conscious goats.
Olsson K; Hossaini-Hilali J; Eriksson L
Acta Physiol Scand; 1992 Aug; 145(4):385-94. PubMed ID: 1388314
[TBL] [Abstract][Full Text] [Related]
14. Pressure-dependent distal tubular action of atrial natriuretic peptide in healthy humans.
Eiskjaer H; Nielsen CB; Pedersen EB
J Hypertens; 1996 Jan; 14(1):99-106. PubMed ID: 12013501
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic actions of a new synthetic vasoactive and natriuretic peptide, dendroaspis natriuretic peptide, in experimental severe congestive heart failure.
Lisy O; Lainchbury JG; Leskinen H; Burnett JC
Hypertension; 2001 Apr; 37(4):1089-94. PubMed ID: 11304508
[TBL] [Abstract][Full Text] [Related]
16. BNP: pathophysiological and potential therapeutic roles in acute congestive heart failure.
Grantham JA; Borgeson DD; Burnett JC
Am J Physiol; 1997 Apr; 272(4 Pt 2):R1077-83. PubMed ID: 9140004
[TBL] [Abstract][Full Text] [Related]
17. Renal denervation potentiates the natriuretic and diuretic effects of atrial natriuretic peptide in anaesthetized rabbits.
Christy IJ; Denton KM; Anderson WP
Clin Exp Pharmacol Physiol; 1994 Jan; 21(1):41-8. PubMed ID: 8156651
[TBL] [Abstract][Full Text] [Related]
18. Clearance receptors and endopeptidase: equal role in natriuretic peptide metabolism in heart failure.
Rademaker MT; Charles CJ; Kosoglou T; Protter AA; Espiner EA; Nicholls MG; Richards AM
Am J Physiol; 1997 Nov; 273(5):H2372-9. PubMed ID: 9374774
[TBL] [Abstract][Full Text] [Related]
19. Four-hour atrial natriuretic peptide infusion in conscious rats: effects on urinary volume, sodium, and cyclic GMP.
Campbell HT; Lightfoot BO; Sklar AH
Proc Soc Exp Biol Med; 1988 Dec; 189(3):317-24. PubMed ID: 2849771
[TBL] [Abstract][Full Text] [Related]
20. Natriuretic peptide analogues with distinct vasodilatory or renal activity: integrated effects in health and experimental heart failure.
Rademaker MT; Scott NJA; Koh CY; Kini RM; Richards AM
Cardiovasc Res; 2021 Jan; 117(2):508-519. PubMed ID: 32167565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
